12 Weeks of Water Aerobics at Various Intensities for Adults and Older Adults

July 16, 2024 updated by: Luís Oliveira Brandão Faíl

Effects of 12-week Moderate-intensity vs High-intensity Water-aerobic Training on Physical Fitness, Cardiovascular Health, and Well-being in Adults and Older Adults

The objective of this clinical trial is to understand the best intensity to perform water aerobics with adults and older adults. The main questions it aims to answer are:

  • Is water aerobics performed at high intensity better than water aerobics performed at moderate intensity?
  • Is performing water aerobics for 12 weeks good for muscle strength, body composition (body weight, fat mass), lipid profile (triglycerides, cholesterol), blood pressure, and quality of life in adults and older adults?

Participants need:

  • Perform water aerobics at high or moderate intensity, twice a week, 45 minutes per class, for 12 weeks
  • Be evaluated in the week before starting the water aerobics program (week 0) and at the end week of the program (week 12) regarding muscle strength, body composition, lipid profile, blood pressure, and quality of life

It was hypothesized that independently of the level of intensity used, all variables would improve after water aerobics. It was also expected to observe more gains in all parameters in high-intensity water aerobics compared to moderate intensity

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

21

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Abrantes, Portugal, 2205-700
        • Tramagal Municipal Swimming Pool

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • At least 18 years of age

Exclusion Criteria:

  • taking part in another physical exercise program
  • being recently hospitalized
  • having severe motor or cognitive problems
  • having any medical restrictions on physical exercise

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Moderate-intensity Group
Participants performed water aerobics at moderate intensities. Water aerobics classes lasted approximately 45 minutes and were held twice a week for 12 weeks
Water aerobics sessions involved exercises performed at a moderate intensity, between 60% and 70% of the participant's maximum heart rate predicted by their age.
Experimental: High-intensity Group
Participants performed water aerobics at high intensities. Water aerobics classes lasted approximately 45 minutes and were held twice a week for 12 weeks
Water aerobics sessions involved exercises performed at a high intensity, between 80% and 90% of the participant's maximum heart rate predicted by their age.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from Baseline in explosive strength of lower limbs at 12 weeks
Time Frame: Baseline and week 12
The explosive strength of the lower limbs was evaluated using the countermovement jump.Three jumps with countermovement were performed, with participants instructed to jump as high as possible, with one minute of rest between repetitions. A higher jump height corresponds to a better score. In this test, the mean value was considered.
Baseline and week 12
Change from Baseline in explosive strength of upper limbs at 12 weeks
Time Frame: Baseline and week 12
The explosive strength of the upper limbs was evaluated using medicine ball throw. Each participant was encouraged to throw a 3-kilogram medicine ball, as far as possible. The best scores are achieved by throwing the ball as far as possible. In this test, the mean value was considered.
Baseline and week 12
Change from Baseline in endurance strength of lower limbs at 12 weeks
Time Frame: Baseline and week 12
The endurance strength of the lower limbs was assessed using the chair stand test. The chair stand test entailed the participant sitting in the center of the chair with a straight back and feet shoulder-width apart and in full contact with the floor. The upper limbs were crossed at the wrist level and positioned against the chest. Upon receiving the starting signal, the participant rose to maximum extension and returned to the initial sitting position, striving to complete the maximum number of repetitions within a 30-second time frame.
Baseline and week 12
Change from Baseline in endurance strength of upper limbs at 12 weeks
Time Frame: Baseline and week 12
The endurance strength of the upper limbs was assessed using the arm curl test. In this test, the participant was seated in a chair with the back straight and fully leaning against the chair, with their feet flat on the floor. A 2 kg dumbbell was held in their dominant hand, and the test commenced with the forearm in a lower position, near the chair, perpendicular to the floor. Upon receiving the start signal, the participant performed a complete flexion of the forearm and then returned to the initial position of forearm extension. The evaluator encouraged the participant to perform as many repetitions as possible within a time limit of 30 seconds, counting each correct flexion performed.
Baseline and week 12
Change from Baseline in body mass at 12 weeks
Time Frame: Baseline and week 12
A bioimpedance balance was used. For the correct extraction of this test, participants were barefoot and dressed in as little clothing as possible.
Baseline and week 12
Change from Baseline in fat mass percentage at 12 weeks
Time Frame: Baseline and week 12
Baseline and week 12
Change from Baseline in fat-free mass at 12 weeks
Time Frame: Baseline and week 12
Baseline and week 12
Change from Baseline in body mass index at 12 weeks
Time Frame: Baseline and week 12
The body mass index (BMI) was calculated by dividing the body mass value by the height squared (kg/m^2). For this, each participant's height was measured using a precision stadiometer with a scale of 0.001 m. For the correct extraction of this test, participants were barefoot.
Baseline and week 12
Change from Baseline in triglycerides at 12 weeks
Time Frame: Baseline and week 12
Blood samples were collected before exercise (after a 15-minute rest period) and at least 2 hours after the last meal.
Baseline and week 12
Change from Baseline in total cholesterol at 12 weeks
Time Frame: Baseline and week 12
Baseline and week 12
Change from Baseline in diastolic blood pressure at 12 weeks
Time Frame: Baseline and week 12
This measure was assessed using an automatic blood pressure monitor, after the participant was seated and resting for at least 20 minutes.
Baseline and week 12
Change from Baseline in systolic blood pressure at 12 weeks
Time Frame: Baseline and week 12
Baseline and week 12
Change from Baseline in resting heart rate at 12 weeks
Time Frame: Baseline and week 12
This measure was assessed using an automatic blood pressure monitor, after the participant was seated and resting for at least 20 minutes.
Baseline and week 12

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from Baseline in quality of life at 12 weeks
Time Frame: Baseline and week 12
The WHOQOL-BREF (Portuguese version) questionnaire with 26 items was used to assess the participants' quality of life. Of the 26 items, 2 are related to the general quality of life and general health, and the remaining 24 items assess the perception of quality of life in 4 domains: physical, psychological, social relationships, and environment. The higher the final score, the higher the participant's quality of life in each domain.
Baseline and week 12

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Luís Faíl, University of Beira Interior

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 19, 2022

Primary Completion (Actual)

December 16, 2022

Study Completion (Actual)

December 23, 2022

Study Registration Dates

First Submitted

July 11, 2024

First Submitted That Met QC Criteria

July 16, 2024

First Posted (Actual)

July 19, 2024

Study Record Updates

Last Update Posted (Actual)

July 19, 2024

Last Update Submitted That Met QC Criteria

July 16, 2024

Last Verified

July 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Moderate-intensity Group

Subscribe